U-Blot® Research Grade LiraglutideCat. No. WA3088$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade LiraglutideCat. No. WA3088
U-Blot® Research Grade LipustobartCat. No. WA3087
U-Blot® Research Grade LinvoseltamabCat. No. WA3086
U-Blot® Research Grade LintuzumabCat. No. WA3085
U-Blot® Research Grade LinclatamigCat. No. WA3084
U-Blot® Research Grade LinavonkibartCat. No. WA3083
U-Blot® Research Grade LilotomabCat. No. WA3082
U-Blot® Research Grade LigufalimabCat. No. WA3081
U-Blot® Research Grade LigelizumabCat. No. WA3080
U-Blot® Research Grade lifonebartCat. No. WA3079
U-Blot® Research Grade LifastuzumabCat. No. WA3078
U-Blot® Research Grade LicaminlimabCat. No. WA3077